Condition
Mesothelioma
Estimated Enrollment: 50
Age Group: Child, Adult, Senior
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: MARS2
Study First Received: December 20, 2013
Last Updated: April 12, 2016
Estimated Primary Completion Date: May 2017
Primary Outcome Measures:
Ability to randomise 50 patients|Survival from the time point of randomisation|Quality of life as assessed using QLQ 30 and LC-13 scales
Sponsors and Collaborators:
Royal Brompton & Harefield NHS Foundation Trust|Cancer Research UK|Papworth Hospital NHS Foundation Trust
Website Link: https://ClinicalTrials.gov/show/NCT02040272
